[Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer].
Maruyama
Shoji
S
Department of Surgery, Tokyo Toshima Metropolitan Hospital.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001157:Arterial Occlusive Diseases / Q000209:etiology; D015209:Cholangitis, Sclerosing / Q000209:etiology; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D015179:Colorectal Neoplasms / Q000473:pathology*; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D016685:Mitomycin / Q000008:administration & dosage / Q000009:adverse effects; D009325:Nausea / Q000209:etiology; D010437:Peptic Ulcer / Q000209:etiology; D014839:Vomiting / Q000209:etiology
D015251:Epirubicin; D016685:Mitomycin; D002945:Cisplatin; D005472:Fluorouracil